Sílvia Marfil

1.7k total citations
39 papers, 811 citations indexed

About

Sílvia Marfil is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Sílvia Marfil has authored 39 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 28 papers in Virology and 8 papers in Immunology. Recurrent topics in Sílvia Marfil's work include HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (20 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). Sílvia Marfil is often cited by papers focused on HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (20 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). Sílvia Marfil collaborates with scholars based in Spain, United States and Netherlands. Sílvia Marfil's co-authors include Bonaventura Clotet, Javier Martínez‐Picado, Joan Romeu, Roger Paredes, Lidia Ruíz, Eugènia Negredo, Lı́dia Ruiz, Guillem Sirera, Cristina Tural and Julià Blanco and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Sílvia Marfil

37 papers receiving 791 citations

Peers

Countries citing papers authored by Sílvia Marfil

Since Specialization

Citations

This map shows the geographic impact of Sílvia Marfil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sílvia Marfil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sílvia Marfil more than expected).

Fields of papers citing papers by Sílvia Marfil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sílvia Marfil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sílvia Marfil. The network helps show where Sílvia Marfil may publish in the future.

Co-authorship network of co-authors of Sílvia Marfil

This figure shows the co-authorship network connecting the top 25 collaborators of Sílvia Marfil. A scholar is included among the top collaborators of Sílvia Marfil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sílvia Marfil. Sílvia Marfil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species 2025 ·Viruses ·(unknown), Sílvia Marfil, Edwards Pradenas, Julià Blanco, Júlia Vergara‐Alert, Joaquím Segalés	1
2	Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters 2025 ·Journal of Translational Medicine ·Edwards Pradenas, Víctor Urrea, Sílvia Marfil, (unknown), Carmen Aguilar‐Gurrieri, (unknown), Lourdes Mateu, Anna Chamorro, Eulàlia Grau, (unknown), (unknown), (unknown), Benjamin Trinité, Bonaventura Clotet, Julià Blanco	2
3	Demonstration of Antibodies Against SARS-CoV-2, Neutralizing or Binding, in Seroconversion Panels After mRNA-1273, BNT-162b2, and Ad26.COV2.S Vaccine Administration 2023 ·SHILAP Revista de lepidopterología ·F. J. Belda, (unknown), (unknown), (unknown), Ana Vivanco, Sílvia Marfil, Edwards Pradenas, Marta Massanella, Julià Blanco, (unknown), Michael J. Crowley	1
4	Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate 2023 ·Vaccine ·(unknown), Antoni Prenafeta, (unknown), (unknown), (unknown), (unknown), Luis Javier González, (unknown), Edwards Pradenas, Sílvia Marfil, Julià Blanco, Paula Cebollada Rica, (unknown), Andreas Meyerhans, (unknown), Ricard March, (unknown)	5
5	Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North‐Eastern Spain 2022 ·Transboundary and Emerging Diseases ·(unknown), Sílvia Marfil, Edwards Pradenas, Rosa Valle, (unknown), Jordi Rodon, (unknown), Benjamin Trinité, Mariona Parera, Marc Noguera-Julián, Jaume Martorell, Nuria Izquierdo‐Useros, Jorge Carrillo, Bonaventura Clotet, Julià Blanco, Júlia Vergara‐Alert, Joaquím Segalés	9
6	Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients 2022 ·Scientific Reports ·(unknown), Joan Calvet, Antonio Berenguer, Edwards Pradenas, Sílvia Marfil, Marta Massanella, Lourdes Mateu, Benjamin Trinité, (unknown), Marta Arévalo, C. Galisteo, C. Orellana, (unknown), (unknown), (unknown), Bonaventura Clotet, Julià Blanco, Jordi Gratacós	12
7	First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain 2021 ·Viruses ·(unknown), Jordi Rodon, Edwards Pradenas, Sílvia Marfil, Benjamin Trinité, Mariona Parera, (unknown), Anna M. Pou, Guillermo Cantero, Cristina Lorca-Oró, Jorge Carrillo, Nuria Izquierdo‐Useros, Bonaventura Clotet, Marc Noguera-Julián, Julià Blanco, Júlia Vergara‐Alert, Joaquím Segalés	19
8	Stable neutralizing-antibody levels 6 months after mild and severe COVID-19 episode 2021 ·Edwards Pradenas, Benjamin Trinité, Víctor Urrea, Sílvia Marfil, Carlos Ávila‐Nieto, Maria Luisa Rodrı́guez de la Concepción, Ferran Tarrés-Freixas, Nuria Izquierdo‐Useros, Rodolfo Paredes, Lourdes Mateu, Anna Chamorro, Marta Massanella, Jorge F. Carrillo, Bonaventura Clotet, (unknown)	0
9	HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic 2019 ·Scientific Reports ·(unknown), (unknown), Sílvia Marfil, María Pernas, (unknown), Cecilia Cabrera, Víctor Urrea, Concha Casado, Isabel Olivares, (unknown), (unknown), Judith Estévez‐Herrera, Bonaventura Clotet, Lucile Espert, Cecilio López‐Galíndez, Martine Biard‐Piechaczyk, Agustı́n Valenzuela-Fernández, Julià Blanco	16
10	Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers 2018 ·mBio ·Concha Casado, (unknown), (unknown), María Pernas, Sílvia Marfil, (unknown), Isabel Olivares, (unknown), (unknown), Laura de Armas‐Rillo, Philippe Lemey, Julià Blanco, Agustı́n Valenzuela-Fernández, Cecilio López‐Galíndez	35
11	Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif 2017 ·Scientific Reports ·(unknown), (unknown), Luís Agulló, Sílvia Marfil, Elisabet García, Maria Luisa Rodrı́guez de la Concepción, Nuria Izquierdo‐Useros, Cristina Vilaplana, (unknown), F.‐Xabier Contreras, (unknown), Père-Joan Cardona, Javier Martínez‐Picado, Bonaventura Clotet, Jordi Villà‐Freixa, Maier Lorizate, Jorge Carrillo, Julià Blanco	11
12	Anti-MPER Antibodies with Heterogeneous Neutralization Capacity Are Detectable in Most Untreated HIV Infected Individuals 2014 ·AIDS Research and Human Retroviruses ·(unknown), Jorge Carrillo, Marta Curriu, Maria Luisa Rodrı́guez de la Concepción, Sílvia Marfil, (unknown), Bonaventura Clotet, Julià Blanco	0
13	Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals 2014 ·PLoS ONE ·Marta Massanella, Dan Ouchi, Sílvia Marfil, Josep M. Llibre, María C. Puertas, María J. Buzón, Douglas D. Richman, (unknown), Mario Stevenson, Josep M. Gatell, Peré Domingo, Eugènia Negredo, Javier Martínez‐Picado, Bonaventura Clotet, Julià Blanco	18
14	Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals 2014 ·Retrovirology ·(unknown), Jorge Carrillo, Marta Curriu, Maria Luisa Rodrı́guez de la Concepción, Sílvia Marfil, Elisabet García, Bonaventura Clotet, Julià Blanco	18
15	Evaluation of the Cytopathicity (Fusion/Hemifusion) of Patient-Derived HIV-1 Envelope Glycoproteins Comparing Two Effector Cell Lines 2012 ·SLAS DISCOVERY ·(unknown), Marta Curriu, Sílvia Marfil, Elisabet García, Bonaventura Clotet, Julià Blanco, Cecilia Cabrera	7
16	Short Communication: Naive CD4 ⁺ T Cells and Recent Thymic Emigrant Levels in Treated Individuals with HIV: Clinical Relevance 2006 ·AIDS Research and Human Retroviruses ·Margarita Bofill, Javier Martínez‐Picado, (unknown), Cecilia Cabrera, Sílvia Marfil, Itziar Erkizia, Rocío Bellido, Joan Romeu, Bonaventura Clotet, Lidia Ruíz	12
17	Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen 2006 ·AIDS ·Cecilia Cabrera, Sílvia Marfil, Elisabet García, Javier Martínez‐Picado, Anna Bonjoch, Margarita Bofill, Santiago Moreno, Esteban Ribera, Peré Domingo, Bonaventura Clotet, Lidia Ruíz	39
18	HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection 2001 ·AIDS ·Lidia Ruíz, Guislaine Carcelain, Javier Martínez‐Picado, Simon D. W. Frost, Sílvia Marfil, Roger Paredes, Joan Romeu, (unknown), (unknown), Brigitte Autran, Bonaventura Clotet	121
19	Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression 2000 ·AIDS ·Lı́dia Ruiz, Javier Martínez‐Picado, Joan Romeu, Roger Paredes, (unknown), Sílvia Marfil, Eugènia Negredo, Guillem Sirera, Cristina Tural, Bonaventura Clotet	172
20	Efficacy of Adding Indinavir to Previous Reverse Transcriptase Nucleoside Analogues in Relation to Genotypic and Phenotypic Resistance Development in Advanced HIV-1-Infected Patients 1998 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Lı́dia Ruiz, Monique Nijhuis, Charles A. Boucher, Teresa Puig, Anna Bonjoch, Javier Martínez‐Picado, Sílvia Marfil, Dorien de Jong, David M. Burger, Albert Goday, Montserrat Balagué, Bonaventura Clotet	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact